Superior Anti-tumor Efficacy of Bicalutamide 80 mg in Combination with a Luteinizing Hormone-releasing Hormone (LHRH) Agonist Versus LHRH Agonist Monotherapy as First-line Treatment for Advanced Prostate Cancer: Interim Results of a Randomized Study in Japanese Patients

AKAZA H; YAMAGUCHI A; MATSUDA T; IGAWA M; KUMON H; SOEDA A; ARAI Y; USAMI M; NAITO S

Art

J-GLOBAL ID：200902251761525969 Reference number：04A0220599

Superior Anti-tumor Efficacy of Bicalutamide 80 mg in Combination with a Luteinizing Hormone-releasing Hormone (LHRH) Agonist Versus LHRH Agonist Monotherapy as First-line Treatment for Advanced Prostate Cancer: Interim Results of a Randomized Study in Japanese Patients

進行性前立腺癌の第一選択治療法としてのビカルタミド80mgと黄体化ホルモン放出ホルモン(LHRH)アゴニストの併用療法vsLHRHアゴニスト単剤療法の優れた抗腫よう作用日本人患者を対象とした無作為化研究の中間結果

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=04A0220599&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=04A0220599&from=J-GLOBAL&jstjournalNo=X0100A") }}

Author (9)： , , , , , , , ,
Material：
Volume： 34 Issue： 1 Page： 20-28 Publication year： Jan. 2004
JST Material Number： X0100A ISSN： 0368-2811 Document type： Article
Article type：原著論文 Country of issue： Japan (JPN) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=04A0220599&from=J-GLOBAL&jstjournalNo=X0100A") }}

Clinical application of antitumor(=antineoplastic)drugs , Urogenital tumors(=neoplasms) , Drug therapy(=pharmacotherapy)for tumors

, ,

, , , , , , , , , , , ,

Return to Previous Page